Agilent Technologies, Inc. (A) FY2024 Annual P&L / Income Statement

Agilent Technologies, Inc. (A) FY2024 Annual P&L / Income Statement

Income statement for 2023-11-01 through 2024-10-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Net revenue

6,510,000,000 US dollars

Cost of revenue

2,975,000,000 US dollars

Gross profit (calculated)

3,535,000,000 US dollars

Operating expenses (calculated)

2,047,000,000 US dollars

Income from operations

1,488,000,000 US dollars

Other income (expense), net (calculated)

33,000,000 US dollars

Income before taxes, as reported

1,521,000,000 US dollars

Provision for income taxes

232,000,000 US dollars

Net Income

1,289,000,000 US dollars

Life Sciences and Applied Markets

3,215,000,000 US dollars

Diagnostics and Genomics

1,651,000,000 US dollars

Agilent CrossLab

1,644,000,000 US dollars

Research and development

479,000,000 US dollars

Selling, general and administrative

1,568,000,000 US dollars

Life Sciences and Applied Markets costs (calculated)

2,338,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Diagnostics and Genomics costs (calculated)

1,331,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Agilent CrossLab costs (calculated)

1,120,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Reconciling items (calculated)

233,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.